Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Apigenin and ellagic acid may help manage PCOS symptoms.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Analog 23 is a promising compound for prostate cancer treatment.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Stopping Viviscal, a hair loss product, normalized the woman's elevated alkaline phosphatase levels.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Polygonum multiflorum may help treat hair loss but can be toxic to the liver.

Finasteride helps female-pattern hair loss.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Baricitinib helps treat severe hair loss in people over 65.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Targeting ornithine decarboxylase can help prevent skin cancer.